Conversely, PRMT5-catalyzed SDMA of SRSF1 was shown to control cassette-exon choice in acute myeloid leukemia (Radzisheuskaya et al, 2019), underscoring the conserved role of SRSF1 methylation across cancers. Here, PRMT5 is linked to cancer.